About Special Hospital for Rheumatic Diseases Novi Sad
Clinical Trials at Special Hospital for Rheumatic Diseases Novi Sad
During the past decade, Special Hospital for Rheumatic Diseases Novi Sad conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on
average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Special Hospital for Rheumatic Diseases Novi Sad" #1 sponsor was "Pfizer" with 4 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Light Chain Bioscience - Novimmune SA"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Special Hospital for Rheumatic Diseases Novi Sad"
#1 collaborator was "Hexal AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Special Hospital for Rheumatic Diseases Novi Sad
According to Clinical.Site data, the most researched conditions in "Special Hospital for Rheumatic Diseases Novi Sad" are
"Rheumatoid Arthritis" (9 trials), "Arthritis, Psoriatic" (1 trials), "Chronic Pain" (1 trials), "Osteoarthritis, Hip" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Special Hospital for Rheumatic Diseases Novi Sad" in a lesser frequency.
Clinical Trials Intervention Types at Special Hospital for Rheumatic Diseases Novi Sad
Most popular intervention types in "Special Hospital for Rheumatic Diseases Novi Sad" are "Drug" (8 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Adalimumab" (2 trials), "GDC-0853" (2 trials), "PF-06410293" (2 trials) and "Adalimumab - GP2017" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Special Hospital for Rheumatic Diseases Novi Sad
The vast majority of trials in "Special Hospital for Rheumatic Diseases Novi Sad" are
11 trials for "All" genders.
Clinical Trials Status at Special Hospital for Rheumatic Diseases Novi Sad
Currently, there are NaN active trials in "Special Hospital for Rheumatic Diseases Novi Sad".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Special Hospital for Rheumatic Diseases Novi Sad,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Special Hospital for Rheumatic Diseases Novi Sad, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".